Inventiva S.A. (IVA)

Acerca de Inventiva S.A.

Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.

Al 3 de noviembre de 2026, la acción de Inventiva S.A. (IVA) se disparó a $4.07, un alza de 6.14% (+$0.24) frente al cierre anterior. En la sesión, las acciones han operado entre $3.78 y $4.17. Eso ubica a IVA en el tercio inferior de su rango de 52 semanas, de $2.82 a $7.29. Inventiva S.A. tiene una capitalización de mercado de aproximadamente $862.26 millones, con cerca de 2.68 millones de acciones negociadas.

Últimas noticias de IVA

• Inventiva (IVA) vs. CRSP and MDGL: Can Lanifibranor’s Phase 3 Trial Unlock 62% Upside?Yahoo Finance· 28 oct, 9:13 a.m. ET
• 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Aheadmarketbeat.com· 10 oct, 10:35 a.m. ET
• Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026Yahoo Finance· 6 oct, 4:05 p.m. ET
• Inventiva (IVA): How Much Is One Make-or-Break Readout Really Worth?Yahoo Finance· 4 oct, 3:26 p.m. ET
• Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Testmarketbeat.com· 4 oct, 1:02 a.m. ET
• European Equities Traded in the US as American Depositary Receipts Lower in Tuesday TradingYahoo Finance· 29 sep, 11:07 a.m. ET
• Inventiva (IVA) Q2 2026 Earnings Call Transcriptfool.com· 29 sep, 10:00 a.m. ET
• Inventiva SA (IVEVF) (H1 2026) Earnings Call Highlights: Lanifibranor Nears Phase 3 Readout ...Yahoo Finance· 28 sep, 3:00 p.m. ETIVEVF

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de IVA en un solo lugar? Crea una cuenta gratis →

• $IVA $431.3M in Rezdiffra sales in one quarter, up 50% YoY. Hats off to $MDGL for opening this market for MASH patients. This is why I’m excited for $IVA. Doctors are already looking for MASH and prescribing an oral treatment. Imagine a strong NATiV3 readout landing in that ma…

  @Jyoudoit· 3 nov, 7:47 a.m. ET

• Breaking 🚨 $IVA Inventiva listed 15 new job openings on LinkedIn today. Not suggesting this means the data are positive. Just an interesting development worth keeping an eye on. DYOR. NFA.

  @Jyoudoit· 2 nov, 5:13 p.m. ET

• $IVA data imminent lets go

  @Bovan· 2 nov, 12:09 p.m. ET· Alcista

• @Daemeke I believe $IVA gets good results. I think they should get Share Price appreciation. It's an ADR so it sometimes has weird share prices (and corrections) so it becomes a difficult predictor in many cases (we've seen it drop a buck to correct the US price and th…

  @BioRich· 31 oct, 9:58 a.m. ET· Alcista

• $IVA closed the week at $3.65 (-1.6% w/w, -2.1% Friday), below the 50-day SMA ($3.82) and below the 200-day ($4.88). RSI14 53.8. Support $2.82, resistance $3.87 (20-day range, top). Broad market sell-off on Friday. New hub updated: https://www.merlintrader.com/inventiva-iva-st…

  @Merlintrader· 31 oct, 5:24 a.m. ET

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →